Vitrolife Q4: No bumps in the night (or quarter)
Vitrolife reported the results from the fourth-quarter results earlier this morning. Sales in Q4 came in higher than expected, but the EBIT was in line with our estimate. We are encouraged by the strong growth in the time-lapse business unit, but are concerned by the potentially faster-than-expected gross margin erosion.